Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Zebrafish | 82 | 2023 | 2996 | 5.390 |
Why?
|
Cardiomyopathy, Dilated | 21 | 2023 | 851 | 4.010 |
Why?
|
Zebrafish Proteins | 27 | 2023 | 1005 | 3.100 |
Why?
|
Drug Discovery | 10 | 2021 | 1058 | 2.390 |
Why?
|
Cardiomyopathy, Hypertrophic | 26 | 2023 | 1265 | 2.120 |
Why?
|
Cardiomyopathies | 20 | 2024 | 1912 | 2.080 |
Why?
|
Myocytes, Cardiac | 26 | 2023 | 1629 | 2.040 |
Why?
|
Heart | 34 | 2024 | 4464 | 2.000 |
Why?
|
Long QT Syndrome | 8 | 2014 | 453 | 1.660 |
Why?
|
Genetic Testing | 20 | 2022 | 3444 | 1.580 |
Why?
|
Atrial Fibrillation | 24 | 2023 | 5035 | 1.510 |
Why?
|
Models, Animal | 12 | 2017 | 2173 | 1.390 |
Why?
|
Cardiovascular Diseases | 25 | 2023 | 15159 | 1.380 |
Why?
|
Myocardium | 24 | 2024 | 4772 | 1.260 |
Why?
|
Lamin Type A | 8 | 2023 | 190 | 1.250 |
Why?
|
Heart Conduction System | 6 | 2015 | 1047 | 1.220 |
Why?
|
Arrhythmias, Cardiac | 12 | 2021 | 2269 | 1.200 |
Why?
|
Potassium Channels, Voltage-Gated | 8 | 2010 | 142 | 1.170 |
Why?
|
Death, Sudden, Cardiac | 9 | 2023 | 1541 | 1.160 |
Why?
|
Cyanides | 6 | 2023 | 83 | 1.130 |
Why?
|
Brugada Syndrome | 2 | 2023 | 97 | 1.050 |
Why?
|
Genomics | 14 | 2022 | 5717 | 1.040 |
Why?
|
Phenotype | 33 | 2023 | 16367 | 1.030 |
Why?
|
Sarcomeres | 7 | 2019 | 374 | 1.030 |
Why?
|
Systems Biology | 3 | 2020 | 469 | 0.970 |
Why?
|
Indazoles | 2 | 2022 | 290 | 0.960 |
Why?
|
Arrhythmogenic Right Ventricular Dysplasia | 7 | 2014 | 161 | 0.960 |
Why?
|
Heart Failure | 17 | 2023 | 10895 | 0.920 |
Why?
|
Heart Block | 7 | 2013 | 410 | 0.880 |
Why?
|
Mutation | 42 | 2024 | 29786 | 0.870 |
Why?
|
Ethylenediamines | 1 | 2022 | 48 | 0.870 |
Why?
|
Muscle Proteins | 7 | 2015 | 1158 | 0.830 |
Why?
|
Cardiovascular System | 7 | 2021 | 831 | 0.830 |
Why?
|
Biomedical Research | 7 | 2019 | 3309 | 0.800 |
Why?
|
Genetic Predisposition to Disease | 35 | 2023 | 17445 | 0.780 |
Why?
|
Cardiography, Impedance | 1 | 2020 | 41 | 0.760 |
Why?
|
Drug Evaluation, Preclinical | 9 | 2019 | 1375 | 0.760 |
Why?
|
Myosin Light Chains | 2 | 2019 | 121 | 0.730 |
Why?
|
Animals | 114 | 2024 | 168770 | 0.730 |
Why?
|
Molecular Diagnostic Techniques | 3 | 2016 | 602 | 0.710 |
Why?
|
Cardiac Output | 2 | 2021 | 854 | 0.700 |
Why?
|
Friedreich Ataxia | 2 | 2018 | 76 | 0.700 |
Why?
|
Gene Expression Regulation, Developmental | 17 | 2023 | 3617 | 0.700 |
Why?
|
Cardiology | 5 | 2016 | 1668 | 0.690 |
Why?
|
Academies and Institutes | 2 | 2019 | 317 | 0.680 |
Why?
|
Embryo, Nonmammalian | 19 | 2016 | 895 | 0.670 |
Why?
|
Stroke Volume | 10 | 2024 | 5006 | 0.670 |
Why?
|
Potassium Cyanide | 1 | 2018 | 16 | 0.660 |
Why?
|
Humans | 217 | 2024 | 744376 | 0.650 |
Why?
|
Genetic Markers | 6 | 2014 | 2634 | 0.640 |
Why?
|
Medical History Taking | 3 | 2018 | 784 | 0.630 |
Why?
|
Pyruvate Dehydrogenase Complex | 1 | 2018 | 57 | 0.630 |
Why?
|
Animals, Genetically Modified | 16 | 2020 | 1549 | 0.620 |
Why?
|
Industry | 1 | 2019 | 365 | 0.590 |
Why?
|
National Institutes of Health (U.S.) | 3 | 2016 | 780 | 0.570 |
Why?
|
Software Design | 1 | 2016 | 176 | 0.550 |
Why?
|
Amyloidosis | 6 | 2022 | 796 | 0.520 |
Why?
|
Electrocardiography | 14 | 2024 | 6442 | 0.520 |
Why?
|
Cardiovascular Agents | 4 | 2019 | 850 | 0.520 |
Why?
|
Genetic Variation | 13 | 2020 | 6542 | 0.510 |
Why?
|
Induced Pluripotent Stem Cells | 3 | 2023 | 1736 | 0.510 |
Why?
|
Heart Arrest | 2 | 2023 | 1470 | 0.510 |
Why?
|
Myocardial Contraction | 7 | 2014 | 1579 | 0.500 |
Why?
|
Nadolol | 1 | 2014 | 30 | 0.490 |
Why?
|
Calcium Channels, L-Type | 2 | 2019 | 240 | 0.490 |
Why?
|
Metabolomics | 4 | 2018 | 1485 | 0.480 |
Why?
|
Disease Models, Animal | 20 | 2023 | 18034 | 0.480 |
Why?
|
Receptors, Atrial Natriuretic Factor | 1 | 2013 | 54 | 0.480 |
Why?
|
alpha-Galactosidase | 1 | 2014 | 57 | 0.470 |
Why?
|
Monitoring, Physiologic | 1 | 2021 | 1739 | 0.470 |
Why?
|
Chromosomes, Human, Pair 9 | 1 | 2015 | 535 | 0.460 |
Why?
|
RNA-Binding Proteins | 5 | 2022 | 1903 | 0.460 |
Why?
|
Chromosome Mapping | 14 | 2016 | 4740 | 0.460 |
Why?
|
Genome, Human | 7 | 2016 | 4420 | 0.460 |
Why?
|
Hyperglycemia | 2 | 2022 | 1373 | 0.460 |
Why?
|
Program Development | 2 | 2019 | 1316 | 0.460 |
Why?
|
Rare Diseases | 1 | 2018 | 553 | 0.460 |
Why?
|
Regeneration | 7 | 2019 | 1485 | 0.450 |
Why?
|
Fabry Disease | 1 | 2014 | 90 | 0.450 |
Why?
|
Natriuretic Peptide, Brain | 5 | 2022 | 1572 | 0.450 |
Why?
|
Glycolipids | 1 | 2014 | 204 | 0.450 |
Why?
|
Sodium Channels | 4 | 2018 | 349 | 0.440 |
Why?
|
gamma Catenin | 3 | 2014 | 44 | 0.440 |
Why?
|
Electric Conductivity | 4 | 2010 | 411 | 0.440 |
Why?
|
Coronary Disease | 4 | 2018 | 6077 | 0.440 |
Why?
|
Sphingolipids | 1 | 2014 | 159 | 0.430 |
Why?
|
Terminology as Topic | 1 | 2020 | 1547 | 0.430 |
Why?
|
Scleroderma, Systemic | 1 | 2016 | 323 | 0.430 |
Why?
|
Voltage-Sensitive Dye Imaging | 1 | 2012 | 31 | 0.430 |
Why?
|
Cyclin-Dependent Kinase Inhibitor p16 | 1 | 2015 | 705 | 0.420 |
Why?
|
Transcription Factors | 16 | 2024 | 12209 | 0.420 |
Why?
|
Genetic Diseases, Inborn | 2 | 2015 | 587 | 0.420 |
Why?
|
Lipid Metabolism | 1 | 2020 | 1889 | 0.410 |
Why?
|
Defibrillators, Implantable | 3 | 2020 | 1440 | 0.410 |
Why?
|
Pedigree | 23 | 2018 | 4642 | 0.410 |
Why?
|
Polymorphism, Single Nucleotide | 13 | 2023 | 15520 | 0.400 |
Why?
|
Antidotes | 4 | 2023 | 138 | 0.400 |
Why?
|
Metabolome | 1 | 2018 | 895 | 0.400 |
Why?
|
Medicine | 2 | 2017 | 946 | 0.400 |
Why?
|
Desmosomes | 3 | 2010 | 73 | 0.400 |
Why?
|
Toxicity Tests | 1 | 2011 | 121 | 0.390 |
Why?
|
Chromosomes, Human, Pair 12 | 2 | 2011 | 462 | 0.380 |
Why?
|
Coronary Artery Disease | 4 | 2019 | 6486 | 0.380 |
Why?
|
Genome | 3 | 2020 | 1807 | 0.380 |
Why?
|
Anti-Arrhythmia Agents | 2 | 2013 | 789 | 0.380 |
Why?
|
Potassium Channels | 5 | 2018 | 563 | 0.380 |
Why?
|
Hypertrophy, Left Ventricular | 6 | 2023 | 857 | 0.380 |
Why?
|
Natriuretic Peptides | 1 | 2011 | 150 | 0.370 |
Why?
|
Atrial Natriuretic Factor | 3 | 2018 | 393 | 0.370 |
Why?
|
Genome-Wide Association Study | 16 | 2023 | 12262 | 0.370 |
Why?
|
Heart Atria | 6 | 2019 | 1356 | 0.370 |
Why?
|
High-Throughput Screening Assays | 4 | 2019 | 944 | 0.370 |
Why?
|
Peripartum Period | 1 | 2011 | 133 | 0.360 |
Why?
|
Organogenesis | 2 | 2011 | 222 | 0.360 |
Why?
|
Parathyroid Hormone-Related Protein | 1 | 2011 | 331 | 0.350 |
Why?
|
Ether-A-Go-Go Potassium Channels | 6 | 2014 | 70 | 0.350 |
Why?
|
Goiter | 1 | 2010 | 87 | 0.350 |
Why?
|
KCNQ1 Potassium Channel | 6 | 2019 | 104 | 0.350 |
Why?
|
DNA-Binding Proteins | 9 | 2024 | 9647 | 0.350 |
Why?
|
Luciferases | 1 | 2011 | 733 | 0.350 |
Why?
|
Wnt Proteins | 3 | 2014 | 721 | 0.350 |
Why?
|
User-Computer Interface | 1 | 2016 | 1431 | 0.350 |
Why?
|
Psoriasis | 1 | 2017 | 902 | 0.340 |
Why?
|
Medical Informatics | 1 | 2016 | 745 | 0.340 |
Why?
|
Hypertension | 6 | 2022 | 8479 | 0.340 |
Why?
|
Thrombosis | 2 | 2022 | 2968 | 0.330 |
Why?
|
Vascular Diseases | 1 | 2017 | 1161 | 0.330 |
Why?
|
Organ Culture Techniques | 2 | 2014 | 813 | 0.330 |
Why?
|
Microtubule-Associated Proteins | 3 | 2023 | 1085 | 0.330 |
Why?
|
Fellowships and Scholarships | 1 | 2017 | 1078 | 0.330 |
Why?
|
Hearing Loss, Sensorineural | 4 | 2010 | 770 | 0.320 |
Why?
|
Desmoplakins | 2 | 2019 | 62 | 0.320 |
Why?
|
Education, Medical | 2 | 2017 | 1722 | 0.320 |
Why?
|
Genes, Regulator | 1 | 2009 | 378 | 0.320 |
Why?
|
Family | 4 | 2019 | 3147 | 0.320 |
Why?
|
Genetic Linkage | 14 | 2006 | 2421 | 0.320 |
Why?
|
Receptor, Notch1 | 2 | 2014 | 502 | 0.320 |
Why?
|
Ion Channel Gating | 1 | 2010 | 437 | 0.320 |
Why?
|
Transforming Growth Factor beta | 1 | 2015 | 2007 | 0.300 |
Why?
|
Blood Circulation | 1 | 2008 | 251 | 0.300 |
Why?
|
Chromosomes, Human, Pair 10 | 2 | 2006 | 287 | 0.300 |
Why?
|
Female | 90 | 2024 | 380200 | 0.300 |
Why?
|
Male | 90 | 2024 | 350118 | 0.290 |
Why?
|
Pregnancy Complications, Cardiovascular | 1 | 2011 | 500 | 0.290 |
Why?
|
American Heart Association | 6 | 2018 | 1057 | 0.290 |
Why?
|
Atherosclerosis | 2 | 2020 | 3444 | 0.290 |
Why?
|
Heart Rate | 6 | 2020 | 4091 | 0.280 |
Why?
|
Neovascularization, Physiologic | 5 | 2018 | 1351 | 0.280 |
Why?
|
Genetic Association Studies | 4 | 2020 | 2703 | 0.280 |
Why?
|
Neuregulins | 1 | 2006 | 35 | 0.280 |
Why?
|
Middle Aged | 62 | 2023 | 213388 | 0.280 |
Why?
|
Molecular Targeted Therapy | 3 | 2016 | 2726 | 0.280 |
Why?
|
Genetics, Medical | 1 | 2009 | 338 | 0.270 |
Why?
|
Glyoxylates | 2 | 2023 | 10 | 0.270 |
Why?
|
Membrane Potentials | 1 | 2009 | 1137 | 0.270 |
Why?
|
Receptors, Notch | 3 | 2015 | 739 | 0.260 |
Why?
|
Aging, Premature | 1 | 2005 | 47 | 0.260 |
Why?
|
Delivery of Health Care | 2 | 2020 | 5321 | 0.260 |
Why?
|
Angiotensin II Type 1 Receptor Blockers | 2 | 2019 | 451 | 0.260 |
Why?
|
Quantitative Trait Loci | 3 | 2023 | 2019 | 0.260 |
Why?
|
Genotype | 11 | 2019 | 12952 | 0.250 |
Why?
|
Electrophysiological Phenomena | 3 | 2012 | 315 | 0.250 |
Why?
|
Forecasting | 5 | 2016 | 2951 | 0.250 |
Why?
|
Disease | 2 | 2017 | 680 | 0.250 |
Why?
|
Chromosomes, Human, Pair 6 | 2 | 2003 | 380 | 0.250 |
Why?
|
Intercellular Signaling Peptides and Proteins | 3 | 2007 | 1677 | 0.240 |
Why?
|
Action Potentials | 5 | 2023 | 1806 | 0.240 |
Why?
|
Membrane Proteins | 5 | 2020 | 7882 | 0.240 |
Why?
|
Homeodomain Proteins | 5 | 2023 | 2418 | 0.240 |
Why?
|
Signal Transduction | 12 | 2016 | 23406 | 0.240 |
Why?
|
Response Elements | 1 | 2005 | 312 | 0.240 |
Why?
|
Renin | 2 | 2017 | 642 | 0.240 |
Why?
|
Diabetes Mellitus, Type 2 | 3 | 2023 | 11725 | 0.240 |
Why?
|
Polymorphism, Genetic | 7 | 2009 | 4328 | 0.240 |
Why?
|
Isolated Noncompaction of the Ventricular Myocardium | 2 | 2014 | 22 | 0.240 |
Why?
|
Gene Knockdown Techniques | 5 | 2015 | 1656 | 0.230 |
Why?
|
Acute Coronary Syndrome | 2 | 2016 | 2337 | 0.230 |
Why?
|
Mechanotransduction, Cellular | 2 | 2022 | 541 | 0.230 |
Why?
|
Chromosome Disorders | 4 | 2014 | 514 | 0.220 |
Why?
|
Wolff-Parkinson-White Syndrome | 3 | 2005 | 117 | 0.220 |
Why?
|
Penetrance | 4 | 2010 | 381 | 0.220 |
Why?
|
Disease Management | 3 | 2020 | 2460 | 0.220 |
Why?
|
Physical Chromosome Mapping | 1 | 2003 | 183 | 0.220 |
Why?
|
Receptors, Adrenergic, beta-1 | 1 | 2002 | 51 | 0.220 |
Why?
|
Mitogen-Activated Protein Kinase 14 | 1 | 2022 | 28 | 0.220 |
Why?
|
Receptors, Adrenergic, alpha-2 | 1 | 2002 | 64 | 0.220 |
Why?
|
Bradycardia | 2 | 2011 | 307 | 0.220 |
Why?
|
Calcium | 6 | 2022 | 5755 | 0.210 |
Why?
|
Cation Transport Proteins | 2 | 2003 | 327 | 0.210 |
Why?
|
Plakophilins | 3 | 2014 | 34 | 0.210 |
Why?
|
Heart Diseases | 4 | 2024 | 2789 | 0.200 |
Why?
|
Ventricular Remodeling | 3 | 2023 | 1223 | 0.200 |
Why?
|
Co-Repressor Proteins | 1 | 2022 | 194 | 0.200 |
Why?
|
Heart Valve Diseases | 3 | 2015 | 1074 | 0.200 |
Why?
|
Poisoning | 1 | 2023 | 249 | 0.200 |
Why?
|
Receptors, Lysophospholipid | 1 | 2020 | 39 | 0.200 |
Why?
|
Longevity | 3 | 2023 | 1071 | 0.190 |
Why?
|
Specimen Handling | 1 | 2006 | 694 | 0.190 |
Why?
|
Feasibility Studies | 3 | 2021 | 5077 | 0.190 |
Why?
|
Ventricular Function, Left | 4 | 2024 | 3666 | 0.190 |
Why?
|
Publishing | 1 | 2008 | 833 | 0.190 |
Why?
|
RNA Splicing | 4 | 2017 | 908 | 0.190 |
Why?
|
Platinum | 1 | 2022 | 233 | 0.190 |
Why?
|
Intracranial Aneurysm | 3 | 2016 | 1197 | 0.190 |
Why?
|
Aneurysm, Ruptured | 2 | 2016 | 452 | 0.190 |
Why?
|
Risk Factors | 23 | 2023 | 72295 | 0.190 |
Why?
|
DNA | 3 | 2014 | 7294 | 0.190 |
Why?
|
Cardiomegaly | 3 | 2022 | 620 | 0.190 |
Why?
|
Myocardial Infarction | 4 | 2023 | 11718 | 0.190 |
Why?
|
Adult | 49 | 2023 | 214056 | 0.190 |
Why?
|
Body Patterning | 5 | 2018 | 626 | 0.180 |
Why?
|
Mutation, Missense | 7 | 2017 | 2566 | 0.180 |
Why?
|
Algorithms | 10 | 2020 | 13882 | 0.180 |
Why?
|
Tubulin | 1 | 2023 | 695 | 0.180 |
Why?
|
Rabbits | 7 | 2022 | 4894 | 0.180 |
Why?
|
Therapies, Investigational | 1 | 2020 | 112 | 0.180 |
Why?
|
Clinical Trials, Phase II as Topic | 1 | 2022 | 629 | 0.180 |
Why?
|
Lod Score | 6 | 2006 | 614 | 0.180 |
Why?
|
Registries | 1 | 2015 | 8091 | 0.170 |
Why?
|
MAP Kinase Signaling System | 3 | 2015 | 1525 | 0.170 |
Why?
|
Artificial Intelligence | 4 | 2024 | 2213 | 0.170 |
Why?
|
Echocardiography | 6 | 2022 | 5099 | 0.170 |
Why?
|
Immunoglobulin lambda-Chains | 1 | 2019 | 87 | 0.170 |
Why?
|
Hematology | 1 | 2022 | 221 | 0.170 |
Why?
|
United States | 18 | 2019 | 69869 | 0.170 |
Why?
|
Case-Control Studies | 13 | 2020 | 21747 | 0.170 |
Why?
|
Endothelium, Vascular | 6 | 2016 | 4458 | 0.170 |
Why?
|
Cell Proliferation | 9 | 2019 | 10484 | 0.160 |
Why?
|
Connexin 43 | 1 | 2019 | 207 | 0.160 |
Why?
|
Information Dissemination | 3 | 2017 | 1099 | 0.160 |
Why?
|
Pharmaceutical Preparations | 2 | 2021 | 1070 | 0.160 |
Why?
|
Online Systems | 1 | 2019 | 184 | 0.160 |
Why?
|
Clinical Trials, Phase III as Topic | 1 | 2022 | 841 | 0.160 |
Why?
|
Sodium-Glucose Transporter 1 | 1 | 2018 | 112 | 0.160 |
Why?
|
Public-Private Sector Partnerships | 1 | 2019 | 121 | 0.160 |
Why?
|
Myoblasts, Cardiac | 1 | 2018 | 23 | 0.160 |
Why?
|
Lysophospholipids | 1 | 2020 | 331 | 0.160 |
Why?
|
Syndrome | 7 | 2011 | 3252 | 0.160 |
Why?
|
Risk Assessment | 11 | 2022 | 23336 | 0.160 |
Why?
|
Ion Channels | 2 | 2022 | 1056 | 0.160 |
Why?
|
Telemedicine | 3 | 2020 | 2872 | 0.160 |
Why?
|
Subarachnoid Hemorrhage | 2 | 2016 | 1018 | 0.160 |
Why?
|
Interdisciplinary Studies | 1 | 2018 | 89 | 0.160 |
Why?
|
Microtubules | 1 | 2023 | 1089 | 0.150 |
Why?
|
Endosomes | 1 | 2020 | 520 | 0.150 |
Why?
|
Receptor, Anaphylatoxin C5a | 1 | 2018 | 90 | 0.150 |
Why?
|
Periodicals as Topic | 1 | 2008 | 1431 | 0.150 |
Why?
|
HEK293 Cells | 8 | 2021 | 4208 | 0.150 |
Why?
|
Wolffian Ducts | 1 | 2017 | 23 | 0.150 |
Why?
|
Pharmacy Service, Hospital | 1 | 2018 | 133 | 0.150 |
Why?
|
Intestinal Absorption | 1 | 2018 | 420 | 0.150 |
Why?
|
Ubiquitin-Protein Ligases | 2 | 2018 | 1862 | 0.150 |
Why?
|
Blood Pressure Monitoring, Ambulatory | 1 | 2019 | 236 | 0.150 |
Why?
|
Disease Susceptibility | 2 | 2022 | 1782 | 0.150 |
Why?
|
Chromosomes, Human, Pair 4 | 2 | 2009 | 374 | 0.150 |
Why?
|
Myofibrils | 1 | 2017 | 146 | 0.150 |
Why?
|
Gene Frequency | 8 | 2020 | 3587 | 0.150 |
Why?
|
Tryptophan-tRNA Ligase | 1 | 2016 | 17 | 0.140 |
Why?
|
Myosins | 4 | 1994 | 409 | 0.140 |
Why?
|
Amino Acid Sequence | 10 | 2017 | 13814 | 0.140 |
Why?
|
Predictive Value of Tests | 5 | 2020 | 15078 | 0.140 |
Why?
|
Cardiotoxins | 2 | 2013 | 41 | 0.140 |
Why?
|
Gene Knockout Techniques | 1 | 2019 | 808 | 0.140 |
Why?
|
Oligonucleotides, Antisense | 3 | 2011 | 433 | 0.140 |
Why?
|
Sequence Analysis, DNA | 5 | 2017 | 4805 | 0.140 |
Why?
|
Medication Reconciliation | 1 | 2018 | 151 | 0.140 |
Why?
|
Biological Evolution | 1 | 2022 | 1077 | 0.140 |
Why?
|
Blood Vessels | 3 | 2010 | 1125 | 0.140 |
Why?
|
Models, Cardiovascular | 2 | 2020 | 996 | 0.140 |
Why?
|
Molecular Sequence Data | 17 | 2015 | 18111 | 0.140 |
Why?
|
Mammals | 3 | 2023 | 1143 | 0.140 |
Why?
|
Cytoskeletal Proteins | 1 | 2022 | 1364 | 0.140 |
Why?
|
Noonan Syndrome | 1 | 2017 | 122 | 0.140 |
Why?
|
Carrier Proteins | 4 | 2017 | 5023 | 0.140 |
Why?
|
Neuregulin-1 | 2 | 2015 | 142 | 0.140 |
Why?
|
MAP Kinase Kinase Kinase 3 | 1 | 2015 | 16 | 0.140 |
Why?
|
Aged | 31 | 2023 | 163284 | 0.140 |
Why?
|
Transcription, Genetic | 6 | 2017 | 7722 | 0.140 |
Why?
|
Thrombospondins | 1 | 2016 | 198 | 0.140 |
Why?
|
Pharmacists | 1 | 2018 | 248 | 0.140 |
Why?
|
Hydroxymethylglutaryl-CoA Reductase Inhibitors | 3 | 2021 | 3255 | 0.140 |
Why?
|
Immunoglobulin Light Chains | 2 | 2014 | 277 | 0.140 |
Why?
|
Cystine-Knot Miniproteins | 1 | 2015 | 4 | 0.140 |
Why?
|
Chromosomes, Human, Pair 7 | 2 | 1999 | 322 | 0.130 |
Why?
|
Health Status | 1 | 2009 | 4033 | 0.130 |
Why?
|
Mice | 20 | 2024 | 81202 | 0.130 |
Why?
|
Physical Examination | 1 | 2022 | 1237 | 0.130 |
Why?
|
Cell Shape | 1 | 2017 | 375 | 0.130 |
Why?
|
Education, Medical, Graduate | 2 | 2019 | 2291 | 0.130 |
Why?
|
Pilot Projects | 7 | 2020 | 8319 | 0.130 |
Why?
|
Ubiquitin | 1 | 2020 | 851 | 0.130 |
Why?
|
Glucose Tolerance Test | 1 | 2018 | 1150 | 0.130 |
Why?
|
Professional Role | 1 | 2018 | 306 | 0.130 |
Why?
|
Base Sequence | 14 | 2012 | 12797 | 0.130 |
Why?
|
Receptors, Vascular Endothelial Growth Factor | 2 | 2015 | 664 | 0.130 |
Why?
|
Anthelmintics | 1 | 2015 | 62 | 0.130 |
Why?
|
Lipoproteins, LDL | 1 | 2018 | 640 | 0.130 |
Why?
|
Primary Health Care | 3 | 2017 | 4557 | 0.130 |
Why?
|
Organisms, Genetically Modified | 2 | 2005 | 64 | 0.120 |
Why?
|
Nuclear Proteins | 5 | 2020 | 5857 | 0.120 |
Why?
|
Gene Expression Profiling | 2 | 2018 | 9445 | 0.120 |
Why?
|
KCNQ Potassium Channels | 2 | 2004 | 18 | 0.120 |
Why?
|
Actins | 4 | 2017 | 2121 | 0.120 |
Why?
|
Microfluidic Analytical Techniques | 1 | 2021 | 828 | 0.120 |
Why?
|
Ventricular Dysfunction, Left | 2 | 2024 | 2073 | 0.120 |
Why?
|
Gene Expression Regulation | 6 | 2015 | 12073 | 0.120 |
Why?
|
T-Box Domain Proteins | 2 | 2015 | 471 | 0.120 |
Why?
|
Chromosomes, Human, Pair 1 | 7 | 2013 | 658 | 0.120 |
Why?
|
Exercise Tolerance | 2 | 2018 | 768 | 0.120 |
Why?
|
Diffusion of Innovation | 2 | 2016 | 725 | 0.120 |
Why?
|
Cyclic GMP-Dependent Protein Kinases | 1 | 2013 | 30 | 0.120 |
Why?
|
C-Reactive Protein | 1 | 2006 | 3778 | 0.120 |
Why?
|
Sequence Analysis | 1 | 2015 | 256 | 0.120 |
Why?
|
Genes, ras | 1 | 2017 | 690 | 0.120 |
Why?
|
Quality of Life | 3 | 2023 | 12803 | 0.120 |
Why?
|
Intercellular Junctions | 1 | 2014 | 203 | 0.120 |
Why?
|
Quantitative Trait, Heritable | 1 | 2017 | 544 | 0.120 |
Why?
|
Smad2 Protein | 1 | 2014 | 156 | 0.120 |
Why?
|
Data Mining | 2 | 2016 | 537 | 0.120 |
Why?
|
Chemical Engineering | 1 | 2013 | 16 | 0.120 |
Why?
|
Government Programs | 1 | 2016 | 275 | 0.120 |
Why?
|
Blood Pressure | 4 | 2019 | 8551 | 0.120 |
Why?
|
Apolipoproteins | 1 | 2016 | 317 | 0.110 |
Why?
|
Smad1 Protein | 1 | 2013 | 81 | 0.110 |
Why?
|
Cardiotonic Agents | 2 | 2014 | 535 | 0.110 |
Why?
|
Heart Ventricles | 4 | 2015 | 3817 | 0.110 |
Why?
|
Kidney Glomerulus | 2 | 2016 | 697 | 0.110 |
Why?
|
Child | 19 | 2023 | 77708 | 0.110 |
Why?
|
Plant Proteins | 1 | 2015 | 364 | 0.110 |
Why?
|
Parathion | 1 | 2012 | 14 | 0.110 |
Why?
|
Endothelial Cells | 5 | 2020 | 3486 | 0.110 |
Why?
|
Environment | 1 | 2019 | 1123 | 0.110 |
Why?
|
Phosphatidylinositol 3-Kinases | 1 | 2023 | 2938 | 0.110 |
Why?
|
Muscular Dystrophy, Duchenne | 1 | 2015 | 256 | 0.110 |
Why?
|
Atrioventricular Block | 1 | 2014 | 120 | 0.110 |
Why?
|
Adolescent | 23 | 2023 | 85784 | 0.110 |
Why?
|
Mendelian Randomization Analysis | 2 | 2018 | 967 | 0.110 |
Why?
|
Genes, Neoplasm | 1 | 2014 | 376 | 0.110 |
Why?
|
Animals, Newborn | 5 | 2018 | 2726 | 0.110 |
Why?
|
Health Education | 1 | 2019 | 1056 | 0.110 |
Why?
|
Riboflavin | 1 | 2013 | 108 | 0.110 |
Why?
|
Heart Defects, Congenital | 4 | 2018 | 4583 | 0.110 |
Why?
|
Access to Information | 1 | 2015 | 320 | 0.110 |
Why?
|
Swine | 2 | 2023 | 5918 | 0.110 |
Why?
|
Databases, Factual | 2 | 2019 | 7730 | 0.110 |
Why?
|
HSP70 Heat-Shock Proteins | 1 | 2014 | 404 | 0.100 |
Why?
|
Renin-Angiotensin System | 1 | 2017 | 758 | 0.100 |
Why?
|
Cardiovascular Physiological Phenomena | 2 | 2012 | 235 | 0.100 |
Why?
|
Drug Design | 2 | 2022 | 1076 | 0.100 |
Why?
|
Carcinogenicity Tests | 1 | 2011 | 41 | 0.100 |
Why?
|
Aneurysm | 1 | 2015 | 339 | 0.100 |
Why?
|
Butadienes | 1 | 2011 | 110 | 0.100 |
Why?
|
Receptors, LDL | 1 | 2014 | 476 | 0.100 |
Why?
|
Drug Industry | 1 | 2018 | 746 | 0.100 |
Why?
|
Research Report | 1 | 2015 | 355 | 0.100 |
Why?
|
Histones | 1 | 2022 | 2599 | 0.100 |
Why?
|
Troponin T | 3 | 2018 | 754 | 0.100 |
Why?
|
Pharmacokinetics | 1 | 2011 | 88 | 0.100 |
Why?
|
Stroke | 4 | 2023 | 9981 | 0.100 |
Why?
|
Apoptosis | 3 | 2019 | 9726 | 0.100 |
Why?
|
Doxorubicin | 2 | 2020 | 2234 | 0.100 |
Why?
|
Lipoproteins, HDL | 1 | 2016 | 638 | 0.100 |
Why?
|
Causality | 1 | 2018 | 1275 | 0.100 |
Why?
|
Outpatients | 1 | 2019 | 1487 | 0.100 |
Why?
|
Severity of Illness Index | 1 | 2009 | 15535 | 0.100 |
Why?
|
Heart Valves | 1 | 2013 | 291 | 0.100 |
Why?
|
Hydroxamic Acids | 2 | 2011 | 494 | 0.100 |
Why?
|
Intracranial Arterial Diseases | 1 | 2011 | 22 | 0.100 |
Why?
|
Aged, 80 and over | 12 | 2020 | 57776 | 0.100 |
Why?
|
Troponin C | 1 | 2010 | 25 | 0.100 |
Why?
|
Peptide Fragments | 3 | 2017 | 5096 | 0.100 |
Why?
|
Mechanical Phenomena | 1 | 2012 | 140 | 0.100 |
Why?
|
Cardiac Pacing, Artificial | 2 | 2012 | 845 | 0.100 |
Why?
|
Cisplatin | 1 | 2017 | 1662 | 0.090 |
Why?
|
Prognosis | 7 | 2019 | 29060 | 0.090 |
Why?
|
Research Design | 3 | 2019 | 5986 | 0.090 |
Why?
|
Anticholesteremic Agents | 1 | 2018 | 979 | 0.090 |
Why?
|
Dyslipidemias | 1 | 2018 | 849 | 0.090 |
Why?
|
CCAAT-Enhancer-Binding Protein-beta | 1 | 2010 | 103 | 0.090 |
Why?
|
Genetic Loci | 2 | 2017 | 2575 | 0.090 |
Why?
|
Tunisia | 1 | 2010 | 33 | 0.090 |
Why?
|
GATA Transcription Factors | 1 | 2010 | 30 | 0.090 |
Why?
|
Endocardial Cushions | 1 | 2009 | 13 | 0.090 |
Why?
|
Genetic Counseling | 1 | 2014 | 600 | 0.090 |
Why?
|
Chromatin | 1 | 2022 | 2934 | 0.090 |
Why?
|
Protein Transport | 3 | 2021 | 1988 | 0.090 |
Why?
|
Small-Conductance Calcium-Activated Potassium Channels | 1 | 2010 | 45 | 0.090 |
Why?
|
Patient Participation | 1 | 2019 | 1457 | 0.090 |
Why?
|
Antineoplastic Agents | 2 | 2024 | 13695 | 0.090 |
Why?
|
Trans-Activators | 3 | 2008 | 2926 | 0.090 |
Why?
|
Mass Screening | 2 | 2019 | 5255 | 0.090 |
Why?
|
Aorta | 2 | 2015 | 2062 | 0.090 |
Why?
|
Promoter Regions, Genetic | 3 | 2017 | 5868 | 0.090 |
Why?
|
Angiopoietin-1 | 1 | 2010 | 114 | 0.090 |
Why?
|
Cyclic AMP | 1 | 2013 | 1472 | 0.090 |
Why?
|
Feedback, Physiological | 1 | 2012 | 479 | 0.090 |
Why?
|
ras Proteins | 1 | 2015 | 1060 | 0.090 |
Why?
|
Chondroitin Sulfates | 1 | 2009 | 187 | 0.090 |
Why?
|
Lysosomes | 1 | 2014 | 893 | 0.090 |
Why?
|
Kruppel-Like Transcription Factors | 2 | 2015 | 504 | 0.090 |
Why?
|
Young Adult | 13 | 2022 | 56434 | 0.090 |
Why?
|
Calcium Signaling | 2 | 2011 | 721 | 0.080 |
Why?
|
Spliceosomes | 1 | 2009 | 110 | 0.080 |
Why?
|
Coronary Circulation | 2 | 2007 | 1572 | 0.080 |
Why?
|
Muscle, Skeletal | 3 | 2015 | 4925 | 0.080 |
Why?
|
Evolution, Molecular | 1 | 2018 | 1939 | 0.080 |
Why?
|
Cohort Studies | 8 | 2017 | 40558 | 0.080 |
Why?
|
Alternative Splicing | 2 | 2011 | 1117 | 0.080 |
Why?
|
Catheter Ablation | 3 | 2018 | 2758 | 0.080 |
Why?
|
Computational Biology | 3 | 2017 | 3519 | 0.080 |
Why?
|
Therapeutics | 1 | 2009 | 116 | 0.080 |
Why?
|
Tryptophan | 1 | 2010 | 478 | 0.080 |
Why?
|
Cell Line | 3 | 2019 | 16000 | 0.080 |
Why?
|
Atrioventricular Node | 1 | 2009 | 182 | 0.080 |
Why?
|
Teaching | 1 | 2016 | 1174 | 0.080 |
Why?
|
Bone Morphogenetic Proteins | 1 | 2013 | 838 | 0.080 |
Why?
|
Policy Making | 1 | 2012 | 554 | 0.080 |
Why?
|
Connective Tissue Diseases | 1 | 2011 | 264 | 0.080 |
Why?
|
Amyloid | 1 | 2013 | 795 | 0.080 |
Why?
|
Death, Sudden | 1 | 2010 | 302 | 0.080 |
Why?
|
Carcinoma, Medullary | 1 | 2008 | 123 | 0.080 |
Why?
|
Molecular Sequence Annotation | 1 | 2010 | 528 | 0.080 |
Why?
|
Drug Delivery Systems | 2 | 2011 | 2219 | 0.080 |
Why?
|
Pharmacogenetics | 3 | 2020 | 674 | 0.080 |
Why?
|
Cell Movement | 3 | 2015 | 5218 | 0.080 |
Why?
|
Hematopoietic System | 1 | 2008 | 109 | 0.080 |
Why?
|
Risk Management | 1 | 2011 | 571 | 0.080 |
Why?
|
Electrophysiologic Techniques, Cardiac | 2 | 2008 | 493 | 0.080 |
Why?
|
Cell Adhesion | 1 | 2014 | 3144 | 0.080 |
Why?
|
Randomized Controlled Trials as Topic | 2 | 2022 | 9957 | 0.080 |
Why?
|
Genes, Reporter | 1 | 2011 | 1547 | 0.080 |
Why?
|
Apoptosis Regulatory Proteins | 1 | 2013 | 1157 | 0.080 |
Why?
|
Hyperplasia | 1 | 2011 | 1185 | 0.080 |
Why?
|
Software | 3 | 2016 | 4442 | 0.070 |
Why?
|
Aortic Diseases | 1 | 2013 | 743 | 0.070 |
Why?
|
Peptidyl-Dipeptidase A | 1 | 2009 | 365 | 0.070 |
Why?
|
Protein Isoforms | 2 | 2010 | 1730 | 0.070 |
Why?
|
Physical Conditioning, Animal | 1 | 2010 | 354 | 0.070 |
Why?
|
Desmocollins | 1 | 2006 | 12 | 0.070 |
Why?
|
Multifactorial Inheritance | 1 | 2014 | 1194 | 0.070 |
Why?
|
MicroRNAs | 2 | 2013 | 3751 | 0.070 |
Why?
|
Species Specificity | 2 | 2015 | 2478 | 0.070 |
Why?
|
Arginine | 1 | 2010 | 944 | 0.070 |
Why?
|
Proto-Oncogene Proteins c-ret | 1 | 2008 | 220 | 0.070 |
Why?
|
Cardiopulmonary Bypass | 1 | 1992 | 1066 | 0.070 |
Why?
|
Nitriles | 1 | 2011 | 955 | 0.070 |
Why?
|
Autophagy | 1 | 2014 | 1297 | 0.070 |
Why?
|
Codon | 1 | 2008 | 611 | 0.070 |
Why?
|
Magnetic Resonance Imaging, Cine | 1 | 2013 | 964 | 0.070 |
Why?
|
Muscles | 1 | 2011 | 1614 | 0.070 |
Why?
|
Nitric Oxide | 1 | 2015 | 2132 | 0.070 |
Why?
|
Histone Deacetylase Inhibitors | 1 | 2011 | 789 | 0.070 |
Why?
|
Practice Guidelines as Topic | 2 | 2020 | 7281 | 0.070 |
Why?
|
Caenorhabditis elegans | 1 | 2015 | 1418 | 0.070 |
Why?
|
Glucocorticoids | 1 | 2015 | 2108 | 0.070 |
Why?
|
Green Fluorescent Proteins | 2 | 2017 | 2088 | 0.070 |
Why?
|
Luciferases, Renilla | 1 | 2005 | 21 | 0.070 |
Why?
|
Nerve Tissue Proteins | 3 | 2014 | 4464 | 0.070 |
Why?
|
Tropomyosin | 3 | 1995 | 102 | 0.070 |
Why?
|
In Situ Hybridization | 4 | 2013 | 1950 | 0.070 |
Why?
|
Sodium-Potassium-Exchanging ATPase | 1 | 2008 | 494 | 0.070 |
Why?
|
Mitochondria | 2 | 2016 | 3514 | 0.070 |
Why?
|
Blood Cells | 2 | 2023 | 309 | 0.070 |
Why?
|
Luciferases, Firefly | 1 | 2005 | 46 | 0.070 |
Why?
|
Human Genome Project | 2 | 2017 | 193 | 0.070 |
Why?
|
Potassium Channels, Inwardly Rectifying | 1 | 2006 | 150 | 0.070 |
Why?
|
Core Binding Factor Alpha 2 Subunit | 1 | 2008 | 345 | 0.070 |
Why?
|
Lethal Dose 50 | 2 | 2017 | 77 | 0.070 |
Why?
|
Ubiquitination | 2 | 2020 | 1012 | 0.060 |
Why?
|
Gastrointestinal Tract | 1 | 2011 | 814 | 0.060 |
Why?
|
Time Factors | 10 | 2019 | 40077 | 0.060 |
Why?
|
Glycoproteins | 1 | 2013 | 2266 | 0.060 |
Why?
|
Angiogenesis Inhibitors | 1 | 2015 | 2038 | 0.060 |
Why?
|
Luminescent Agents | 1 | 2005 | 54 | 0.060 |
Why?
|
Renal Circulation | 1 | 2006 | 334 | 0.060 |
Why?
|
Interdisciplinary Communication | 3 | 2016 | 950 | 0.060 |
Why?
|
Pyrazoles | 1 | 2015 | 1972 | 0.060 |
Why?
|
Hedgehog Proteins | 1 | 2010 | 783 | 0.060 |
Why?
|
Protein Kinases | 1 | 2012 | 1640 | 0.060 |
Why?
|
Galectin 3 | 1 | 2006 | 227 | 0.060 |
Why?
|
Kidney Diseases | 1 | 2016 | 2148 | 0.060 |
Why?
|
Ligands | 2 | 2022 | 3282 | 0.060 |
Why?
|
Ultrasonography | 3 | 2007 | 5984 | 0.060 |
Why?
|
Ear, Inner | 1 | 2008 | 420 | 0.060 |
Why?
|
Endothelin-1 | 1 | 2006 | 314 | 0.060 |
Why?
|
Gene Dosage | 1 | 2009 | 1252 | 0.060 |
Why?
|
Glucuronidase | 1 | 2005 | 207 | 0.060 |
Why?
|
Multivariate Analysis | 3 | 2009 | 12244 | 0.060 |
Why?
|
Haplotypes | 4 | 2007 | 2779 | 0.060 |
Why?
|
Genes, Dominant | 5 | 2000 | 880 | 0.060 |
Why?
|
Electrocardiography, Ambulatory | 2 | 2005 | 585 | 0.060 |
Why?
|
MERRF Syndrome | 1 | 2003 | 4 | 0.060 |
Why?
|
Basic Helix-Loop-Helix Transcription Factors | 2 | 2008 | 1115 | 0.060 |
Why?
|
Cloning, Organism | 1 | 2003 | 54 | 0.060 |
Why?
|
RNA Splice Sites | 2 | 2017 | 209 | 0.060 |
Why?
|
Alleles | 4 | 2022 | 6933 | 0.060 |
Why?
|
Systole | 1 | 2006 | 958 | 0.060 |
Why?
|
Dose-Response Relationship, Drug | 2 | 2014 | 10943 | 0.060 |
Why?
|
Pyrimidines | 1 | 2015 | 2943 | 0.060 |
Why?
|
Age of Onset | 4 | 2020 | 3270 | 0.060 |
Why?
|
Mitochondrial Myopathies | 1 | 2003 | 47 | 0.060 |
Why?
|
Cell Count | 2 | 2011 | 1856 | 0.060 |
Why?
|
Prevalence | 3 | 2011 | 15221 | 0.060 |
Why?
|
Cells, Cultured | 6 | 2021 | 19233 | 0.060 |
Why?
|
Neovascularization, Pathologic | 1 | 2013 | 2638 | 0.060 |
Why?
|
Ear | 1 | 2003 | 173 | 0.060 |
Why?
|
Rats | 6 | 2022 | 24252 | 0.050 |
Why?
|
Thyroidectomy | 1 | 2008 | 879 | 0.050 |
Why?
|
Heart Transplantation | 2 | 2017 | 3112 | 0.050 |
Why?
|
Treatment Outcome | 5 | 2019 | 63115 | 0.050 |
Why?
|
Neutrophil Activation | 1 | 2023 | 186 | 0.050 |
Why?
|
Epilepsies, Myoclonic | 1 | 2003 | 80 | 0.050 |
Why?
|
Lamins | 2 | 2018 | 36 | 0.050 |
Why?
|
Receptors, Adrenergic | 1 | 2002 | 155 | 0.050 |
Why?
|
Biological Assay | 1 | 2005 | 652 | 0.050 |
Why?
|
Morbidity | 1 | 2008 | 1768 | 0.050 |
Why?
|
Homeostasis | 2 | 2018 | 3339 | 0.050 |
Why?
|
Sequence Homology, Amino Acid | 2 | 2017 | 2839 | 0.050 |
Why?
|
Structure-Activity Relationship | 2 | 2020 | 3130 | 0.050 |
Why?
|
Conserved Sequence | 1 | 2005 | 1202 | 0.050 |
Why?
|
Larva | 2 | 2015 | 519 | 0.050 |
Why?
|
Repetitive Sequences, Nucleic Acid | 2 | 1994 | 798 | 0.050 |
Why?
|
Aortic Coarctation | 1 | 2004 | 281 | 0.050 |
Why?
|
Phylogeny | 2 | 2022 | 2804 | 0.050 |
Why?
|
Hematopoietic Stem Cells | 1 | 2014 | 3390 | 0.050 |
Why?
|
Anthracyclines | 1 | 2024 | 288 | 0.050 |
Why?
|
Environmental Exposure | 1 | 2016 | 4232 | 0.050 |
Why?
|
Sulfides | 1 | 2022 | 165 | 0.050 |
Why?
|
Verapamil | 1 | 2022 | 244 | 0.050 |
Why?
|
Acidosis, Lactic | 1 | 2003 | 142 | 0.050 |
Why?
|
Dimethyl Sulfoxide | 1 | 2022 | 249 | 0.050 |
Why?
|
Adrenergic beta-Antagonists | 2 | 2021 | 1240 | 0.050 |
Why?
|
Multienzyme Complexes | 1 | 2005 | 686 | 0.050 |
Why?
|
Introns | 4 | 2010 | 992 | 0.050 |
Why?
|
Double-Blind Method | 3 | 2021 | 12025 | 0.050 |
Why?
|
Pyruvic Acid | 1 | 2022 | 200 | 0.050 |
Why?
|
Pediatrics | 1 | 2016 | 3475 | 0.050 |
Why?
|
Immunoassay | 1 | 2005 | 752 | 0.050 |
Why?
|
beta Catenin | 1 | 2006 | 1059 | 0.050 |
Why?
|
Receptors, Angiotensin | 1 | 2021 | 142 | 0.050 |
Why?
|
Organ Specificity | 1 | 2006 | 2008 | 0.050 |
Why?
|
Microsatellite Repeats | 1 | 2003 | 802 | 0.050 |
Why?
|
Receptors, Lysophosphatidic Acid | 1 | 2020 | 76 | 0.050 |
Why?
|
Enzyme Inhibitors | 1 | 2011 | 3799 | 0.050 |
Why?
|
Canada | 2 | 2019 | 2065 | 0.050 |
Why?
|
Chromosomes, Human, Pair 2 | 2 | 1999 | 326 | 0.050 |
Why?
|
Desmin | 1 | 2000 | 130 | 0.050 |
Why?
|
Rats, Wistar | 2 | 2014 | 1892 | 0.050 |
Why?
|
Models, Theoretical | 1 | 2013 | 3589 | 0.050 |
Why?
|
DNA Mutational Analysis | 3 | 2017 | 4185 | 0.050 |
Why?
|
Mice, Inbred C57BL | 5 | 2021 | 21833 | 0.050 |
Why?
|
Inflammation | 2 | 2017 | 10636 | 0.050 |
Why?
|
Oxygen Consumption | 1 | 2007 | 1868 | 0.050 |
Why?
|
Down-Regulation | 1 | 2008 | 3001 | 0.050 |
Why?
|
Cadherins | 2 | 2015 | 907 | 0.050 |
Why?
|
Antibiotics, Antineoplastic | 1 | 2024 | 692 | 0.040 |
Why?
|
Norepinephrine | 1 | 2002 | 909 | 0.040 |
Why?
|
Coronary Angiography | 1 | 1992 | 4576 | 0.040 |
Why?
|
alpha 1-Antitrypsin | 1 | 2020 | 163 | 0.040 |
Why?
|
Oncogene Proteins, Fusion | 1 | 2008 | 1581 | 0.040 |
Why?
|
Linear Models | 3 | 2017 | 5952 | 0.040 |
Why?
|
Age Factors | 4 | 2019 | 18373 | 0.040 |
Why?
|
Genetic Techniques | 2 | 2000 | 435 | 0.040 |
Why?
|
Fibrosis | 1 | 2006 | 2029 | 0.040 |
Why?
|
Sex Factors | 3 | 2007 | 10400 | 0.040 |
Why?
|
Hemodynamics | 2 | 2023 | 4196 | 0.040 |
Why?
|
Bundle of His | 1 | 1999 | 87 | 0.040 |
Why?
|
Follow-Up Studies | 7 | 2019 | 39052 | 0.040 |
Why?
|
Cell Lineage | 1 | 2008 | 2504 | 0.040 |
Why?
|
Electrophysiology | 2 | 2014 | 1308 | 0.040 |
Why?
|
Carotid Arteries | 1 | 2003 | 950 | 0.040 |
Why?
|
Pacemaker, Artificial | 2 | 2017 | 816 | 0.040 |
Why?
|
Sphingosine | 1 | 2020 | 307 | 0.040 |
Why?
|
Models, Genetic | 1 | 2009 | 3493 | 0.040 |
Why?
|
Epicardial Mapping | 1 | 2018 | 57 | 0.040 |
Why?
|
Neprilysin | 1 | 2021 | 439 | 0.040 |
Why?
|
Infant, Newborn | 3 | 2017 | 25628 | 0.040 |
Why?
|
Drug Interactions | 1 | 2003 | 1460 | 0.040 |
Why?
|
Nuclear Pore | 1 | 2018 | 70 | 0.040 |
Why?
|
Referral and Consultation | 4 | 2017 | 3529 | 0.040 |
Why?
|
Ambystoma mexicanum | 1 | 2018 | 47 | 0.040 |
Why?
|
Exons | 4 | 2013 | 2439 | 0.040 |
Why?
|
Chromatin Assembly and Disassembly | 1 | 2022 | 635 | 0.040 |
Why?
|
Chi-Square Distribution | 2 | 2017 | 3508 | 0.040 |
Why?
|
Denmark | 1 | 2019 | 738 | 0.040 |
Why?
|
Prospective Studies | 6 | 2020 | 53291 | 0.040 |
Why?
|
Confidence Intervals | 1 | 2003 | 2971 | 0.040 |
Why?
|
Proteins | 2 | 2020 | 6100 | 0.040 |
Why?
|
Morphogenesis | 1 | 2020 | 752 | 0.040 |
Why?
|
Electron Transport Complex IV | 1 | 2017 | 189 | 0.040 |
Why?
|
Carotid Artery Diseases | 1 | 2003 | 879 | 0.040 |
Why?
|
Embryonic Development | 2 | 2013 | 711 | 0.040 |
Why?
|
Research | 1 | 2005 | 1999 | 0.040 |
Why?
|
Sulfur | 1 | 2017 | 166 | 0.040 |
Why?
|
Proto-Oncogene Proteins | 2 | 2008 | 4554 | 0.040 |
Why?
|
Protein Tyrosine Phosphatase, Non-Receptor Type 11 | 1 | 2017 | 234 | 0.040 |
Why?
|
Japan | 1 | 2020 | 1360 | 0.030 |
Why?
|
Health Communication | 1 | 2019 | 214 | 0.030 |
Why?
|
Gene Duplication | 1 | 2017 | 329 | 0.030 |
Why?
|
Myxoma | 1 | 1997 | 130 | 0.030 |
Why?
|
Chromosomes, Human, Pair 20 | 1 | 1996 | 133 | 0.030 |
Why?
|
Avian Proteins | 1 | 1996 | 80 | 0.030 |
Why?
|
Central Nervous System | 1 | 2003 | 1357 | 0.030 |
Why?
|
Receptor, Platelet-Derived Growth Factor beta | 1 | 2017 | 188 | 0.030 |
Why?
|
Blood Platelets | 1 | 2007 | 2509 | 0.030 |
Why?
|
Internship and Residency | 1 | 2016 | 5789 | 0.030 |
Why?
|
Liver | 1 | 2011 | 7475 | 0.030 |
Why?
|
Mutagenesis | 1 | 2020 | 1264 | 0.030 |
Why?
|
Stress, Mechanical | 2 | 2014 | 1686 | 0.030 |
Why?
|
Latent TGF-beta Binding Proteins | 1 | 2015 | 42 | 0.030 |
Why?
|
Genes | 1 | 2020 | 1893 | 0.030 |
Why?
|
Chromosomes, Mammalian | 1 | 2016 | 151 | 0.030 |
Why?
|
Vagotomy | 1 | 2015 | 83 | 0.030 |
Why?
|
Protein Structure, Tertiary | 2 | 2014 | 3848 | 0.030 |
Why?
|
Chromosomes, Human, Pair 14 | 1 | 1996 | 299 | 0.030 |
Why?
|
United States Dept. of Health and Human Services | 1 | 2016 | 90 | 0.030 |
Why?
|
Electron Transport Complex II | 1 | 2015 | 48 | 0.030 |
Why?
|
Mitogen-Activated Protein Kinase 7 | 1 | 2015 | 66 | 0.030 |
Why?
|
Mitral Valve Prolapse | 1 | 1997 | 231 | 0.030 |
Why?
|
Peptides, Cyclic | 1 | 2018 | 400 | 0.030 |
Why?
|
Aging | 2 | 2023 | 8663 | 0.030 |
Why?
|
Salivary Proteins and Peptides | 1 | 2015 | 53 | 0.030 |
Why?
|
Codon, Nonsense | 1 | 2016 | 281 | 0.030 |
Why?
|
Brazil | 1 | 2019 | 1270 | 0.030 |
Why?
|
Haploinsufficiency | 1 | 2017 | 328 | 0.030 |
Why?
|
Solubility | 1 | 2017 | 1088 | 0.030 |
Why?
|
Biotransformation | 1 | 2015 | 168 | 0.030 |
Why?
|
Ectromelia | 1 | 1995 | 31 | 0.030 |
Why?
|
Thyroid Neoplasms | 1 | 2008 | 2282 | 0.030 |
Why?
|
Angiotensin Receptor Antagonists | 1 | 2021 | 923 | 0.030 |
Why?
|
Genetic Heterogeneity | 2 | 1997 | 733 | 0.030 |
Why?
|
Vitamin D-Binding Protein | 1 | 2016 | 129 | 0.030 |
Why?
|
Excitation Contraction Coupling | 1 | 2014 | 25 | 0.030 |
Why?
|
Hemangioblasts | 1 | 2014 | 28 | 0.030 |
Why?
|
Hominidae | 1 | 1995 | 74 | 0.030 |
Why?
|
Patient Acceptance of Health Care | 2 | 2019 | 3020 | 0.030 |
Why?
|
Neoplastic Syndromes, Hereditary | 1 | 1997 | 241 | 0.030 |
Why?
|
Chromosomes, Human, Pair 11 | 1 | 1995 | 417 | 0.030 |
Why?
|
Nerve Growth Factor | 1 | 2015 | 149 | 0.030 |
Why?
|
Acute Disease | 2 | 2020 | 7147 | 0.030 |
Why?
|
Regulatory Elements, Transcriptional | 1 | 2015 | 186 | 0.030 |
Why?
|
Asymptomatic Diseases | 1 | 2017 | 551 | 0.030 |
Why?
|
Somites | 1 | 2014 | 62 | 0.030 |
Why?
|
Molecular Dynamics Simulation | 1 | 2017 | 409 | 0.030 |
Why?
|
Protein Binding | 2 | 2020 | 9384 | 0.030 |
Why?
|
Small Molecule Libraries | 1 | 2020 | 720 | 0.030 |
Why?
|
Denervation | 1 | 2015 | 278 | 0.030 |
Why?
|
Angiotensin-Converting Enzyme Inhibitors | 1 | 2021 | 1516 | 0.030 |
Why?
|
Pericytes | 1 | 2017 | 293 | 0.030 |
Why?
|
RNA, Small Interfering | 2 | 2016 | 3505 | 0.030 |
Why?
|
Isoproterenol | 1 | 2014 | 399 | 0.030 |
Why?
|
Hand Deformities, Congenital | 1 | 1995 | 146 | 0.030 |
Why?
|
Receptors, Glucocorticoid | 1 | 2015 | 302 | 0.030 |
Why?
|
Protein Processing, Post-Translational | 1 | 2022 | 1988 | 0.030 |
Why?
|
Dilatation, Pathologic | 1 | 2015 | 520 | 0.030 |
Why?
|
Cell Culture Techniques | 1 | 2021 | 1678 | 0.030 |
Why?
|
England | 2 | 1992 | 522 | 0.030 |
Why?
|
Infant | 3 | 2017 | 35134 | 0.030 |
Why?
|
Chromosome Aberrations | 2 | 1999 | 1813 | 0.030 |
Why?
|
Heart Neoplasms | 1 | 1997 | 374 | 0.030 |
Why?
|
Sex Characteristics | 1 | 2024 | 2585 | 0.030 |
Why?
|
Muscle Cells | 1 | 2014 | 197 | 0.030 |
Why?
|
Molecular Probe Techniques | 1 | 1994 | 119 | 0.030 |
Why?
|
Troponin | 2 | 1994 | 524 | 0.030 |
Why?
|
Fetal Proteins | 1 | 2013 | 94 | 0.030 |
Why?
|
Pralidoxime Compounds | 1 | 2012 | 5 | 0.030 |
Why?
|
Cholinesterase Reactivators | 1 | 2012 | 6 | 0.030 |
Why?
|
Recombination, Genetic | 2 | 1995 | 1586 | 0.030 |
Why?
|
Emetine | 1 | 2012 | 15 | 0.030 |
Why?
|
Eye Proteins | 2 | 2008 | 645 | 0.030 |
Why?
|
Ribonucleases | 1 | 1994 | 287 | 0.030 |
Why?
|
Vascular Endothelial Growth Factor Receptor-2 | 1 | 2016 | 547 | 0.030 |
Why?
|
Metoclopramide | 1 | 2012 | 51 | 0.030 |
Why?
|
Glycopyrrolate | 1 | 2012 | 33 | 0.030 |
Why?
|
Nitroprusside | 1 | 2013 | 275 | 0.030 |
Why?
|
Proteinuria | 1 | 2016 | 658 | 0.030 |
Why?
|
Certification | 1 | 2016 | 423 | 0.030 |
Why?
|
DNA Primers | 4 | 2004 | 2891 | 0.030 |
Why?
|
Health Priorities | 1 | 2016 | 380 | 0.030 |
Why?
|
Myocytes, Smooth Muscle | 1 | 2017 | 687 | 0.030 |
Why?
|
Neostigmine | 1 | 2012 | 69 | 0.030 |
Why?
|
Urinary Tract Physiological Phenomena | 1 | 2012 | 11 | 0.030 |
Why?
|
Glycogen Synthase Kinase 3 | 1 | 2014 | 430 | 0.030 |
Why?
|
Rats, Inbred BN | 1 | 2012 | 235 | 0.030 |
Why?
|
Cholesterol | 1 | 2021 | 2919 | 0.030 |
Why?
|
Mesoderm | 1 | 2015 | 686 | 0.030 |
Why?
|
Inosine | 1 | 2013 | 133 | 0.030 |
Why?
|
In Situ Nick-End Labeling | 1 | 2013 | 644 | 0.030 |
Why?
|
Pirenzepine | 1 | 2012 | 115 | 0.030 |
Why?
|
Atropine | 1 | 2012 | 244 | 0.030 |
Why?
|
Inulin | 1 | 2012 | 84 | 0.030 |
Why?
|
Neurons | 1 | 2011 | 9340 | 0.030 |
Why?
|
Disease Progression | 3 | 2019 | 13285 | 0.030 |
Why?
|
Contractile Proteins | 1 | 1993 | 246 | 0.030 |
Why?
|
Extracellular Matrix Proteins | 1 | 1996 | 850 | 0.030 |
Why?
|
Chromosomes, Human, Pair 15 | 1 | 1993 | 373 | 0.030 |
Why?
|
Cholesterol, LDL | 1 | 2021 | 2355 | 0.030 |
Why?
|
Curriculum | 2 | 2016 | 3605 | 0.030 |
Why?
|
Crosses, Genetic | 1 | 2013 | 791 | 0.030 |
Why?
|
Comparative Genomic Hybridization | 1 | 2013 | 496 | 0.030 |
Why?
|
Podocytes | 1 | 2016 | 396 | 0.030 |
Why?
|
Child, Preschool | 4 | 2019 | 41005 | 0.030 |
Why?
|
Laminin | 1 | 1993 | 419 | 0.030 |
Why?
|
Regional Blood Flow | 1 | 2015 | 1525 | 0.030 |
Why?
|
Sequence Alignment | 1 | 2016 | 2256 | 0.030 |
Why?
|
1-Phosphatidylinositol 4-Kinase | 1 | 2011 | 59 | 0.030 |
Why?
|
Mental Disorders | 1 | 2011 | 6600 | 0.030 |
Why?
|
Pregnancy | 2 | 2011 | 29144 | 0.020 |
Why?
|
Cholinergic Antagonists | 1 | 2012 | 165 | 0.020 |
Why?
|
Oxidation-Reduction | 1 | 2017 | 2184 | 0.020 |
Why?
|
Repressor Proteins | 1 | 2022 | 3024 | 0.020 |
Why?
|
Frameshift Mutation | 1 | 2013 | 399 | 0.020 |
Why?
|
Odds Ratio | 2 | 2017 | 9849 | 0.020 |
Why?
|
Inservice Training | 1 | 2014 | 392 | 0.020 |
Why?
|
Circle of Willis | 1 | 2011 | 68 | 0.020 |
Why?
|
Rats, Inbred F344 | 1 | 2012 | 862 | 0.020 |
Why?
|
Molecular Structure | 1 | 2015 | 1899 | 0.020 |
Why?
|
Reproducibility of Results | 2 | 2022 | 19905 | 0.020 |
Why?
|
Bile Acids and Salts | 1 | 2013 | 368 | 0.020 |
Why?
|
Waiting Lists | 2 | 1992 | 692 | 0.020 |
Why?
|
Chronic Disease | 1 | 2005 | 9145 | 0.020 |
Why?
|
Drug Approval | 1 | 2017 | 742 | 0.020 |
Why?
|
Medical Audit | 1 | 1992 | 467 | 0.020 |
Why?
|
Subcellular Fractions | 1 | 2011 | 547 | 0.020 |
Why?
|
Adenoviridae | 1 | 2014 | 1101 | 0.020 |
Why?
|
Exercise Test | 1 | 2018 | 2073 | 0.020 |
Why?
|
Endocardial Cushion Defects | 1 | 2009 | 45 | 0.020 |
Why?
|
Dietary Supplements | 1 | 2023 | 3296 | 0.020 |
Why?
|
Hyperlipoproteinemia Type II | 1 | 2015 | 373 | 0.020 |
Why?
|
Immunoblotting | 1 | 2013 | 1683 | 0.020 |
Why?
|
Survival Analysis | 3 | 2014 | 10252 | 0.020 |
Why?
|
p38 Mitogen-Activated Protein Kinases | 1 | 2013 | 697 | 0.020 |
Why?
|
Skin | 1 | 2003 | 4371 | 0.020 |
Why?
|
Databases, Genetic | 1 | 2017 | 1783 | 0.020 |
Why?
|
Fruit | 1 | 2015 | 1142 | 0.020 |
Why?
|
N-Acetylgalactosaminyltransferases | 1 | 2009 | 65 | 0.020 |
Why?
|
Sequence Analysis, RNA | 1 | 2018 | 2012 | 0.020 |
Why?
|
Kidney Function Tests | 1 | 2012 | 683 | 0.020 |
Why?
|
Utilization Review | 1 | 1991 | 392 | 0.020 |
Why?
|
Clinical Competence | 2 | 2016 | 4687 | 0.020 |
Why?
|
Microscopy, Fluorescence | 1 | 2017 | 2700 | 0.020 |
Why?
|
Enzyme Activation | 1 | 2015 | 3702 | 0.020 |
Why?
|
Single-Blind Method | 1 | 2013 | 1591 | 0.020 |
Why?
|
Recovery of Function | 1 | 2019 | 2926 | 0.020 |
Why?
|
Cell Survival | 2 | 2013 | 5882 | 0.020 |
Why?
|
Iliac Artery | 1 | 2011 | 364 | 0.020 |
Why?
|
Drug Resistance | 1 | 2015 | 1608 | 0.020 |
Why?
|
Multiprotein Complexes | 1 | 2015 | 1120 | 0.020 |
Why?
|
Immunity | 1 | 2015 | 1014 | 0.020 |
Why?
|
Neoplasms | 2 | 2016 | 21693 | 0.020 |
Why?
|
Lateral Line System | 1 | 2008 | 12 | 0.020 |
Why?
|
Synaptic Transmission | 1 | 2015 | 1178 | 0.020 |
Why?
|
Abnormalities, Multiple | 1 | 1996 | 1416 | 0.020 |
Why?
|
Losartan | 1 | 2011 | 299 | 0.020 |
Why?
|
Calcium Channel Blockers | 1 | 2012 | 692 | 0.020 |
Why?
|
High-Throughput Nucleotide Sequencing | 1 | 2021 | 3596 | 0.020 |
Why?
|
Cell Differentiation | 2 | 2018 | 11486 | 0.020 |
Why?
|
Brain Ischemia | 1 | 2003 | 3265 | 0.020 |
Why?
|
Microscopy, Electron, Transmission | 1 | 2010 | 712 | 0.020 |
Why?
|
Endocardium | 1 | 2009 | 263 | 0.020 |
Why?
|
Caenorhabditis elegans Proteins | 1 | 2015 | 852 | 0.020 |
Why?
|
Random Allocation | 1 | 2013 | 2428 | 0.020 |
Why?
|
Chromosome Deletion | 1 | 2013 | 1401 | 0.020 |
Why?
|
Education, Medical, Continuing | 1 | 2014 | 840 | 0.020 |
Why?
|
Cooperative Behavior | 1 | 2015 | 1504 | 0.020 |
Why?
|
Death | 1 | 2013 | 678 | 0.020 |
Why?
|
Physicians, Primary Care | 1 | 2015 | 591 | 0.020 |
Why?
|
Body Mass Index | 1 | 2006 | 12720 | 0.020 |
Why?
|
Tandem Repeat Sequences | 1 | 2009 | 185 | 0.020 |
Why?
|
Recombinant Fusion Proteins | 1 | 2017 | 3773 | 0.020 |
Why?
|
Syncope | 1 | 2011 | 429 | 0.020 |
Why?
|
Up-Regulation | 1 | 2017 | 4222 | 0.020 |
Why?
|
RNA | 1 | 2018 | 2749 | 0.020 |
Why?
|
Retrospective Studies | 3 | 2023 | 77459 | 0.020 |
Why?
|
Point Mutation | 1 | 1993 | 1624 | 0.020 |
Why?
|
Coronary Vessels | 2 | 2011 | 3107 | 0.020 |
Why?
|
Hong Kong | 1 | 2007 | 148 | 0.020 |
Why?
|
Iceland | 1 | 2007 | 183 | 0.020 |
Why?
|
Protein Conformation | 1 | 2015 | 4010 | 0.020 |
Why?
|
Health Promotion | 1 | 2019 | 2205 | 0.020 |
Why?
|
Erythroid Precursor Cells | 1 | 2008 | 218 | 0.020 |
Why?
|
Computer Simulation | 1 | 2020 | 6194 | 0.020 |
Why?
|
GATA1 Transcription Factor | 1 | 2008 | 293 | 0.020 |
Why?
|
Focus Groups | 1 | 2011 | 1321 | 0.020 |
Why?
|
DNA, Complementary | 2 | 2004 | 2050 | 0.020 |
Why?
|
Proto-Oncogene Proteins c-akt | 1 | 2015 | 2504 | 0.020 |
Why?
|
Heterozygote | 1 | 2013 | 2804 | 0.020 |
Why?
|
Consensus | 1 | 2015 | 2960 | 0.020 |
Why?
|
Glucose | 1 | 2018 | 4398 | 0.020 |
Why?
|
Microscopy, Electron | 1 | 2010 | 2646 | 0.020 |
Why?
|
Genes, Lethal | 1 | 2006 | 242 | 0.020 |
Why?
|
Recurrence | 1 | 2018 | 8340 | 0.020 |
Why?
|
Transfection | 1 | 2014 | 5895 | 0.020 |
Why?
|
Receptor, TIE-2 | 1 | 2006 | 178 | 0.020 |
Why?
|
Cell Line, Tumor | 2 | 2013 | 16692 | 0.020 |
Why?
|
Kaplan-Meier Estimate | 1 | 2017 | 6539 | 0.020 |
Why?
|
Umbilical Veins | 1 | 2006 | 433 | 0.020 |
Why?
|
Phenylephrine | 1 | 2006 | 301 | 0.020 |
Why?
|
Kidney | 1 | 2002 | 7184 | 0.020 |
Why?
|
Self-Injurious Behavior | 1 | 2011 | 464 | 0.020 |
Why?
|
Angiotensin II | 1 | 2009 | 881 | 0.020 |
Why?
|
Hair Cells, Auditory | 1 | 2008 | 361 | 0.020 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 1 | 2013 | 4751 | 0.020 |
Why?
|
Cell Death | 1 | 2011 | 1707 | 0.020 |
Why?
|
RNA Interference | 1 | 2014 | 2891 | 0.020 |
Why?
|
Polymerase Chain Reaction | 3 | 2006 | 6171 | 0.020 |
Why?
|
Osmolar Concentration | 1 | 2006 | 683 | 0.020 |
Why?
|
Health Behavior | 1 | 2017 | 2635 | 0.020 |
Why?
|
Intracellular Signaling Peptides and Proteins | 1 | 2016 | 2916 | 0.020 |
Why?
|
Angiography | 1 | 2011 | 1639 | 0.020 |
Why?
|
Aortic Valve | 1 | 2015 | 1924 | 0.020 |
Why?
|
Violence | 1 | 2011 | 909 | 0.020 |
Why?
|
Linkage Disequilibrium | 1 | 2010 | 1997 | 0.020 |
Why?
|
Models, Molecular | 1 | 2015 | 5451 | 0.020 |
Why?
|
Meta-Analysis as Topic | 1 | 2010 | 1343 | 0.020 |
Why?
|
Internationality | 1 | 2010 | 1002 | 0.020 |
Why?
|
Genetic Vectors | 1 | 2014 | 3424 | 0.020 |
Why?
|
Gene Expression Regulation, Enzymologic | 1 | 2009 | 1213 | 0.020 |
Why?
|
Sweden | 1 | 2007 | 1346 | 0.020 |
Why?
|
Integrases | 1 | 2006 | 533 | 0.010 |
Why?
|
Patient Readmission | 1 | 2018 | 3116 | 0.010 |
Why?
|
Phosphorylation | 1 | 2015 | 8437 | 0.010 |
Why?
|
Body Size | 1 | 2007 | 461 | 0.010 |
Why?
|
Microscopy, Confocal | 1 | 2010 | 1970 | 0.010 |
Why?
|
Health Care Costs | 1 | 2017 | 3209 | 0.010 |
Why?
|
Evidence-Based Medicine | 1 | 2016 | 3610 | 0.010 |
Why?
|
Erythropoiesis | 1 | 2008 | 706 | 0.010 |
Why?
|
Longitudinal Studies | 1 | 2019 | 13988 | 0.010 |
Why?
|
Platelet Aggregation | 1 | 2007 | 798 | 0.010 |
Why?
|
Arteriovenous Malformations | 1 | 2006 | 396 | 0.010 |
Why?
|
Selection Bias | 1 | 2005 | 371 | 0.010 |
Why?
|
Health Policy | 1 | 2016 | 2661 | 0.010 |
Why?
|
Tunica Media | 1 | 2003 | 113 | 0.010 |
Why?
|
Blotting, Northern | 1 | 2005 | 1581 | 0.010 |
Why?
|
Mice, Transgenic | 2 | 2006 | 9735 | 0.010 |
Why?
|
Medical Errors | 1 | 2011 | 1297 | 0.010 |
Why?
|
Qualitative Research | 1 | 2011 | 2682 | 0.010 |
Why?
|
Blood Flow Velocity | 1 | 2006 | 1423 | 0.010 |
Why?
|
Oligodeoxyribonucleotides | 2 | 1994 | 708 | 0.010 |
Why?
|
Muscle, Smooth | 1 | 2006 | 934 | 0.010 |
Why?
|
Immunoprecipitation | 1 | 2005 | 906 | 0.010 |
Why?
|
Diagnosis, Differential | 2 | 2010 | 12961 | 0.010 |
Why?
|
Catecholamines | 1 | 2003 | 387 | 0.010 |
Why?
|
Radiography | 1 | 2013 | 7023 | 0.010 |
Why?
|
Myocardial Reperfusion | 1 | 2003 | 351 | 0.010 |
Why?
|
Organ Size | 1 | 2007 | 2251 | 0.010 |
Why?
|
Coronary Artery Bypass | 1 | 1991 | 2288 | 0.010 |
Why?
|
AMP-Activated Protein Kinases | 1 | 2005 | 610 | 0.010 |
Why?
|
Mitochondria, Heart | 1 | 2003 | 247 | 0.010 |
Why?
|
Adaptor Proteins, Signal Transducing | 1 | 2012 | 2918 | 0.010 |
Why?
|
Electronic Health Records | 1 | 2018 | 4468 | 0.010 |
Why?
|
Antihypertensive Agents | 1 | 2011 | 2047 | 0.010 |
Why?
|
Age Distribution | 1 | 2007 | 2902 | 0.010 |
Why?
|
Microfilament Proteins | 1 | 2006 | 1152 | 0.010 |
Why?
|
Tunica Intima | 1 | 2003 | 464 | 0.010 |
Why?
|
Survival Rate | 2 | 2011 | 12788 | 0.010 |
Why?
|
Embryo, Mammalian | 1 | 2006 | 1701 | 0.010 |
Why?
|
Muscular Dystrophy, Emery-Dreifuss | 1 | 1999 | 22 | 0.010 |
Why?
|
Attitude of Health Personnel | 1 | 2014 | 3842 | 0.010 |
Why?
|
Tomography, Emission-Computed | 1 | 2003 | 1144 | 0.010 |
Why?
|
Family Health | 1 | 2005 | 1281 | 0.010 |
Why?
|
Inpatients | 1 | 2011 | 2518 | 0.010 |
Why?
|
Immunohistochemistry | 1 | 2013 | 11366 | 0.010 |
Why?
|
Thyrotropin | 1 | 2003 | 849 | 0.010 |
Why?
|
In Situ Hybridization, Fluorescence | 2 | 1996 | 2649 | 0.010 |
Why?
|
Health Knowledge, Attitudes, Practice | 1 | 2014 | 3922 | 0.010 |
Why?
|
Aspirin | 1 | 2011 | 3283 | 0.010 |
Why?
|
Models, Biological | 1 | 2015 | 9584 | 0.010 |
Why?
|
Dyspnea | 1 | 2006 | 1303 | 0.010 |
Why?
|
Sensitivity and Specificity | 1 | 1994 | 14723 | 0.010 |
Why?
|
Interviews as Topic | 1 | 2005 | 2539 | 0.010 |
Why?
|
Hospitalization | 1 | 2018 | 10259 | 0.010 |
Why?
|
Monocytes | 1 | 2008 | 2596 | 0.010 |
Why?
|
Rest | 1 | 2003 | 901 | 0.010 |
Why?
|
Protein Kinase Inhibitors | 1 | 2014 | 5535 | 0.010 |
Why?
|
Platelet Aggregation Inhibitors | 1 | 2011 | 3070 | 0.010 |
Why?
|
Anemia | 1 | 2006 | 1503 | 0.010 |
Why?
|
Cardiac Surgical Procedures | 1 | 2012 | 3537 | 0.010 |
Why?
|
Fibrinolytic Agents | 1 | 2007 | 2158 | 0.010 |
Why?
|
Alagille Syndrome | 1 | 1996 | 35 | 0.010 |
Why?
|
Statistics as Topic | 1 | 2003 | 2373 | 0.010 |
Why?
|
Gene Deletion | 1 | 2004 | 2751 | 0.010 |
Why?
|
Blotting, Southern | 1 | 1996 | 803 | 0.010 |
Why?
|
Sequence Tagged Sites | 1 | 1995 | 94 | 0.010 |
Why?
|
Logistic Models | 1 | 2010 | 13409 | 0.010 |
Why?
|
Chickens | 1 | 1996 | 865 | 0.010 |
Why?
|
Receptor, trkA | 1 | 1995 | 164 | 0.010 |
Why?
|
Health Services Accessibility | 1 | 1991 | 5135 | 0.010 |
Why?
|
Receptors, Nerve Growth Factor | 1 | 1995 | 200 | 0.010 |
Why?
|
Tissue Distribution | 1 | 1996 | 2327 | 0.010 |
Why?
|
Leukemia, Myeloid, Acute | 1 | 2008 | 3524 | 0.010 |
Why?
|
Heart Septal Defects, Atrial | 1 | 1995 | 478 | 0.010 |
Why?
|
Mice, Knockout | 1 | 2006 | 14561 | 0.010 |
Why?
|
Genes, MHC Class I | 1 | 1992 | 258 | 0.010 |
Why?
|
Positron-Emission Tomography | 1 | 2007 | 6234 | 0.010 |
Why?
|
Private Practice | 1 | 1991 | 154 | 0.010 |
Why?
|
Massachusetts | 1 | 2003 | 8662 | 0.010 |
Why?
|
Boston | 1 | 2003 | 9312 | 0.010 |
Why?
|
State Medicine | 1 | 1991 | 217 | 0.010 |
Why?
|
Parents | 1 | 2003 | 3405 | 0.010 |
Why?
|
Oncogenes | 1 | 1995 | 1265 | 0.010 |
Why?
|
Troponin I | 1 | 1993 | 619 | 0.010 |
Why?
|
Blood Glucose | 1 | 2003 | 6254 | 0.010 |
Why?
|
Lymphocytes | 1 | 1996 | 2617 | 0.000 |
Why?
|
Probability | 1 | 1993 | 2506 | 0.000 |
Why?
|
Reference Values | 1 | 1995 | 4982 | 0.000 |
Why?
|
Receptor Protein-Tyrosine Kinases | 1 | 1995 | 1660 | 0.000 |
Why?
|
Gene Expression | 1 | 1996 | 7798 | 0.000 |
Why?
|
Quality of Health Care | 1 | 1991 | 4369 | 0.000 |
Why?
|